AD is characterized by Aβ deposition, tau hyperphosphorylation, neuroinflammation, mitochondrial dysfunction, synaptic loss, and reduced nerve growth factor (NGF) levels [238,239]. This evidence concerns the gene MAPT and Alzheimer disease.